Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

European Transfusion Practice and Outcome Study (ETPOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01604083
Recruitment Status : Completed
First Posted : May 23, 2012
Last Update Posted : May 1, 2019
Sponsor:
Information provided by (Responsible Party):
European Society of Anaesthesiology

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of the ETPOS study is to describe differences in transfusion habits throughout Europe and to correlate these habits to perioperative outcome parameters. Special focus is put on the number of PRBCs (packed red blood cells) transfused and the ratio of PRBCs to other blood products or coagulation factors in the operating room. Furthermore the motivation of physicians to transfuse PRBC and blood products in the operating room will be investigated.

Condition or disease
Surgery Erythrocyte Transfusion Habits Anemia Blood Coagulation Disorders

Detailed Description:

In European patients undergoing elective non-cardiac surgery receiving at least one PRBC(packed red blood cells) during their surgery it is proposed to:

  1. Evaluate evidence of differences in the standard of peri-operative transfusion care in different healthcare systems within Europe, and the use of blood conserving techniques.

    1. Evaluate the ratio of transfusion of PRBC to blood products in the operating room
    2. Evaluate which factors determine transfusion of PRBC (is it patient's haemodynamics / haemoglobin threshold/ pressure from the surgeon / acute brisk bleeding / else) and blood products (ratio to PRBC / POC (point of care) monitoring/ per protocol/ else) in the operating room
  2. Evaluate whether there are factors in transfusion therapy that are associated with outcome (in-hospital mortality and unplanned admission to ICU(Intensive Care Unit).)
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 6066 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: European Transfusion Practice and Outcome Study A Multi-central Evaluation of Standard of Transfusion Care and Clinical Outcome for Elective Surgical Patients. Observational Study.
Study Start Date : April 2013
Actual Primary Completion Date : October 2013
Actual Study Completion Date : December 2013

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Amount of PRBC and blood products and coagulation factors transfused [ Time Frame: The Time point at which outcome measure is assessed is during surgery at Day 0 ]
    Amount of packed red blood cells and blood products and coagulation factors: fresh frozen plasmas (FFPs), platelets (PTs) and tranexamic acid transfused


Secondary Outcome Measures :
  1. Factors determining transfusion of PRBC and blood products in different regions of Europe [ Time Frame: The Time point at which outcome measure is assessed is during surgery at Day 0 ]
    Reasons for transfusion of PRBC(packed red blood cells)and blood products in different regions of Europe

  2. 30-day mortality [ Time Frame: The Time point at which outcome measure is assessed is at Day 30 after Surgery ]
    Assesses on Day 30 whether patient is still alive or has died between day zero (Surgery) day 30 after surgery

  3. Unplanned admission to the ICU [ Time Frame: The Time point at which outcome measure is assessed is at Day 30 after Surgery ]
    Assesses on day 30 whether the patient had a Unplanned admission to the Intensive care unit(ICU) following surgery (day 0) until the day 30

  4. Type and frequency of usage of blood conserving techniques [ Time Frame: The Time point at which outcome measure is assessed is at Day 0, on Surgery Day ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients undergoing a non cardiothoracic, non emergency-trauma surgical procedure of participating hospital will be included, if they receive at least one pRBC. There are no further specific inclusion criteria. The only exclusion criteria will be age < 18 years and cardiothoracic and emergency trauma patients.
Criteria

Inclusion Criteria:

- patients undergoing elective non-cardiac surgery commencing during the three-month period and who received at least one erythrocyte concentrate during their intra-operative stay.

Exclusion Criteria:

  • Age < 18 years
  • cardiothoracic surgery
  • emergency trauma patients
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01604083


Locations
Layout table for location information
Croatia
University hospital "Merkur"
Zagreb, Croatia
Czechia
Faculty Hospital Brno
Brno, Czechia
Estonia
North Estonian Center
Tallinn, Estonia
Germany
University Hospital Tübingen University, Germany
Tübingen, Germany
Greece
Aretaieion University Hospital
Athens, Greece
Israel
Tel Aviv Medical Center
Tel Aviv, Israel
Spain
Hospital Vall d Hebron
Barcelona, Spain
Hospital Clínico Universitario de Valencia
Valencia, Spain
Sweden
Sahlgrenska University Hospital
Göteborg, Sweden
Sponsors and Collaborators
European Society of Anaesthesiology
Investigators
Layout table for investigator information
Study Chair: Jens Meier, MD General Hopsital Linz, Linz, Austria
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Other Publications:

Layout table for additonal information
Responsible Party: European Society of Anaesthesiology
ClinicalTrials.gov Identifier: NCT01604083    
Other Study ID Numbers: ETPOS
First Posted: May 23, 2012    Key Record Dates
Last Update Posted: May 1, 2019
Last Verified: April 2016
Keywords provided by European Society of Anaesthesiology:
transfusion
packed red blood cells (PRBC)
Transfusion Practice
Transfusion habits
Outcome
 elective surgery
ETPOS
ESA
European Society of Anaesthesiology
Additional relevant MeSH terms:
Layout table for MeSH terms
Hemostatic Disorders
Blood Coagulation Disorders
Hematologic Diseases
 Vascular Diseases
Cardiovascular Diseases
Hemorrhagic Disorders